Xenon Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer producing branded medicines across multiple therapeutic and dosage-form categories.
Xenon Pharmaceuticals products in Pakistan
Xenon Pharmaceuticals (Pvt.) Ltd has 78 medicine presentations registered in Pakistan under 42 brands, covering 35 generic medicines. Most of its products are in CNS & mental health, Anti-infectives and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Recitan (Levetiracetam), Xeepam (Diazepam), Vetrox (Ceftriaxone) and Profox (Ciprofloxacin). 78 products have an official DRAP price on MedInfoBase. See all 42 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Xenon Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 9.5 K.M Sheikhupura Road, Lahore 54000, Pakistan · 54000
- Website
- xenonpharma.com.pk ↗
- Phone
- +92 42 37921108; +92 42 37929540
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Xenon Pharmaceuticals (Pvt.) Ltd is priced against the market
47 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aspirin | Acetylsalicylic acid (Aspirin) | 300 mg | Tablet | 1000's | 011711 | PKR 134.30 | PKR 0.13/tablet | 🔒 Pharma Pro |
| Ateplex | Clopidogrel | 75 mg | Tablet | 10's | 094022 | PKR 144.75 | PKR 14.48/tablet | 🔒 Pharma Pro |
| Basix Liquid | Furosemide | 10 mg | Oral liquid | 60ml | 040929 | PKR 92.33 | PKR 1.54/mL | No comparator |
| Basix Liquid | Furosemide | 10 mg | Oral liquid | 120 | 040929 | PKR 166.19 | — | No comparator |
| Cefkan | Cefixime | 600 mg | Suspension | 30ml | 029382 | PKR 369.32 | PKR 12.31/mL | No comparator |
| Cefkan | Cefixime | 400 mg | Capsule | 5's | 094615 | PKR 521.86 | PKR 104.37/capsule | 🔒 Pharma Pro |
| Debritone | Phenobarbital | 30 mg | Tablet | 1000's | 016020 | PKR 2,359.95 | PKR 2.36/tablet | 🔒 Pharma Pro |
| Debritone | Phenobarbital | 30 mg | Tablet | 60's | 016020 | PKR 147.49 | PKR 2.46/tablet | 🔒 Pharma Pro |
| Debritone Elixir | Phenobarbital | 4 mg | Elixir | 60ml | 018159 | PKR 119.29 | PKR 1.99/mL | No comparator |
| Debritone Elixir | Phenobarbital | 4 mg | Elixir | 120ml | 018159 | PKR 206.14 | PKR 1.72/mL | No comparator |
| Dermistat | Miconazole | 2 % | Cream | 10gm | 021205 | PKR 57.27 | PKR 5.73/g | 🔒 Pharma Pro |
| DEXAMETHASONE | Dexamethasone | 0.5 mg | Tablet | 1000's | 020546 | PKR 289.04 | PKR 0.29/tablet | 🔒 Pharma Pro |
| Disone | Betamethasone | 0.5 mg | Ointment | 15gm | 029707 | PKR 135.90 | PKR 9.06/g | No comparator |
| Doxin Liquid | Digoxin | 0.05 mg/ml | Liquid | 60ml | 041052 | PKR 67.95 | PKR 1.13/mL | No comparator |
| Doxin Liquid | Digoxin | 0.05 mg/ml | Liquid | 120ml | 041052 | PKR 135.91 | PKR 1.13/mL | No comparator |
| Flunco | Fluconazole | 150 mg | Capsule | 1's | 115646 | PKR 119.86 | PKR 119.86/capsule | 🔒 Pharma Pro |
| Flunco | Fluconazole | 10 mg/ml | Dry suspension | 35ml | 115647 | PKR 279.68 | PKR 7.99/mL | No comparator |
| Hydrocortisone | Hydrocortisone | 10mg | Cream | 5gm | 032329 | PKR 13.32 | PKR 2.66/g | No comparator |
| Hydrocortisone | Hydrocortisone | 10mg | Cream | 10gm | 032329 | PKR 26.63 | PKR 2.66/g | No comparator |
| Kasamol | Paracetamol | 120 mg | Suspension | 60ml | 011708 | PKR 66.01 | PKR 1.10/mL | 🔒 Pharma Pro |
| Korat | Loratadine | 10 mg | Tablet | 10's | 026066 | PKR 187.87 | PKR 18.79/tablet | 🔒 Pharma Pro |
| ODN | Ondansetron | 4 mg/5 mL | Oral solution | 50ml | 113783 | PKR 665.91 | PKR 13.32/mL | 🔒 Pharma Pro |
| ODN-4 | Ondansetron | 4 mg | Tablet | 10's | 113781 | PKR 687.22 | PKR 68.72/tablet | 🔒 Pharma Pro |
| ODN-8 | Ondansetron | 8 mg | Tablet | 10 | 113782 | PKR 1,145.37 | PKR 114.54/tablet | 🔒 Pharma Pro |
| Omrazo | Omeprazole | 20 mg | Capsule | 14's | 026065 | PKR 213.55 | PKR 15.25/capsule | 🔒 Pharma Pro |
| Omrazo | Omeprazole | 40 mg | Capsule | 14's | 057511 | PKR 485.36 | PKR 34.67/capsule | 🔒 Pharma Pro |
| Osmolarz-ORS | Sodium chloride | 1.3 g | Sachet | 20's | 071481 | PKR 428.50 | PKR 21.43/sachet | No comparator |
| PARACETAMOL | Paracetamol | 500 mg | Tablet | 200's | 011710 | PKR 705.01 | PKR 3.53/tablet | 🔒 Pharma Pro |
| PARACETAMOL | Paracetamol | 500 mg | Tablet | 1000's | 011710 | PKR 2,865.29 | PKR 2.87/tablet | 🔒 Pharma Pro |
| Preloid | Prednisolone | 5 mg | Syrup | 60ml | 106331 | PKR 90.33 | PKR 1.51/mL | No comparator |
| Preloid | Prednisolone | 5 mg | Syrup | 120ml | 106331 | PKR 177.04 | PKR 1.48/mL | No comparator |
| Profox | Ciprofloxacin | 250 mg | Tablet | 10's | 053600 | PKR 252.38 | PKR 25.24/tablet | 🔒 Pharma Pro |
| Profox | Ciprofloxacin | 500 mg | Tablet | 10's | 053601 | PKR 417.41 | PKR 41.74/tablet | 🔒 Pharma Pro |
| Profox | Ciprofloxacin | 125 mg | Suspension | 60ml | 069483 | PKR 222.36 | PKR 3.71/mL | No comparator |
| Profox Forte | Ciprofloxacin | 250 mg | Suspension | 60ml | 069482 | PKR 194.14 | PKR 3.24/mL | No comparator |
| Ready | Amitriptyline | 25 mg | Tablet | 100's | 059705 | PKR 147.79 | PKR 1.48/tablet | 🔒 Pharma Pro |
| Recitan | Levetiracetam | 250 mg | Tablet | 10's | 115531 | PKR 348.94 | PKR 34.89/tablet | 🔒 Pharma Pro |
| Recitan | Levetiracetam | 250 mg | Tablet | 30's | 115531 | PKR 1,048.15 | PKR 34.94/tablet | 🔒 Pharma Pro |
| Recitan | Levetiracetam | 500 mg | Tablet | 10's | 115532 | PKR 579.34 | PKR 57.93/tablet | 🔒 Pharma Pro |
| Recitan | Levetiracetam | 500 mg | Tablet | 30's | 115532 | PKR 1,738.04 | PKR 57.93/tablet | 🔒 Pharma Pro |
| Recitan | Levetiracetam | 500 mg/5ml | Oral solution | 10ml | 115533 | PKR 90.56 | PKR 9.06/mL | No comparator |
| Recitan | Levetiracetam | 500 mg/5ml | Oral solution | 15ml | 115533 | PKR 133.18 | PKR 8.88/mL | No comparator |
| Recitan | Levetiracetam | 500 mg/5ml | Oral solution | 30ml | 115533 | PKR 253.04 | PKR 8.43/mL | No comparator |
| Recitan | Levetiracetam | 500 mg/5ml | Oral solution | 60ml | 115533 | PKR 479.45 | PKR 7.99/mL | No comparator |
| Recitan | Levetiracetam | 500 mg/5ml | Oral solution | 120ml | 115533 | PKR 958.91 | PKR 7.99/mL | No comparator |
| Regard | Risperidone | 1 mg | Tablet | 10's | 059721 | PKR 204.96 | PKR 20.50/tablet | 🔒 Pharma Pro |
| Regard | Risperidone | 2 mg | Tablet | 10's | 059722 | PKR 333.06 | PKR 33.31/tablet | 🔒 Pharma Pro |
| Respirate | Salbutamol | 5 mg | Solution | 20ml | 040573 | PKR 31.95 | PKR 1.60/mL | No comparator |
| Siltran | Trimethoprim | 80 mg | Tablet | 200's | 011181 | PKR 173.71 | PKR 0.87/tablet | 🔒 Pharma Pro |
| Siltran D.S | Trimethoprim | 160mg | Tablet | 200's | 020545 | PKR 969.34 | PKR 4.85/tablet | No comparator |
All 42 Xenon Pharmaceuticals brands in Pakistan
- Aspirin Acetylsalicylic acid (Aspirin) · 300 mg tablet
- Ateplex Clopidogrel · 75 mg tablet
- Basix Liquid Furosemide · 10 mg oral liquid
- Cefkan Cefixime · 400 mg capsule, 600 mg suspension
- Debritone Phenobarbital · 30 mg tablet
- Debritone Elixir Phenobarbital · 4 mg solution
- Dermistat Miconazole · 2 % cream
- DEXAMETHASONE Dexamethasone · 0.5 mg tablet
- Disone Betamethasone · 0.5 mg ointment
- Doxin Liquid Digoxin · 0.05 mg/ml liquid
- Flunco Fluconazole · 10 mg/ml suspension, 150 mg capsule
- Hydrocortisone Hydrocortisone · 10mg cream
- Kasamol Paracetamol · 120 mg suspension
- Korat Loratadine · 10 mg tablet
- ODN Ondansetron · 4 mg/5 mL solution
- ODN-4 Ondansetron · 4 mg tablet
- ODN-8 Ondansetron · 8 mg tablet
- Omrazo Omeprazole · 20 mg capsule, 40 mg capsule
- Osmolarz-ORS Sodium chloride · 1.3 g sachet
- PARACETAMOL Paracetamol · 500 mg tablet
- Preloid Prednisolone · 5 mg syrup
- Profox Ciprofloxacin · 125 mg suspension, 250 mg tablet, 500 mg tablet
- Profox Forte Ciprofloxacin · 250 mg suspension
- Ready Amitriptyline · 25 mg tablet
- Recitan Levetiracetam · 250 mg tablet, 500 mg tablet, 500 mg/5ml solution
- Regard Risperidone · 1 mg tablet, 2 mg tablet
- Respirate Salbutamol · 5 mg solution
- Siltran Trimethoprim · 80 mg tablet
- Siltran D.S Trimethoprim · 160mg tablet
- Steron Prednisolone · 15 mg syrup
- Vetrox Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Xeclom Clomifene citrate · 50 mg tablet
- Xedol Albendazole · 200 mg tablet
- Xeeazo Azithromycin · 200 mg suspension, 250 mg tablet
- Xeepam Diazepam · 2 mg tablet, 5 mg solution, 5 mg tablet
- Xelak Lactulose · 3.35 g syrup
- Xepulse Midazolam · 7.5 mg tablet
- Xetac Ranitidine · 150mg tablet
- Xothium Lithium carbonate · 400 mg tablet
- Yoxi Moxifloxacin · 400 mg tablet
- Zefen Ibuprofen · 100 mg suspension
- Zekavir Entecavir · 0.5 mg tablet
Xenon Pharmaceuticals: common questions
How many products does Xenon Pharmaceuticals have in Pakistan?
Xenon Pharmaceuticals (Pvt.) Ltd has 78 registered medicine presentations in Pakistan, sold under 42 brands and covering 35 generic medicines.
What are the main brands of Xenon Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Recitan (Levetiracetam), Xeepam (Diazepam), Vetrox (Ceftriaxone), Profox (Ciprofloxacin) and Zefen (Ibuprofen). This is not a sales ranking.
Which therapy areas does Xenon Pharmaceuticals cover?
The most products are in CNS & mental health (26), Anti-infectives (21), Gastrointestinal & hepatology (7), Pain & musculoskeletal (6) and Cross-therapeutic & anti-inflammatory (5).
Where can I see Xenon Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.